25 01, 2014

Asparaginase Featured in FDA Acrylamide Draft Guidance and FoodDrinkEurope Acrylamide Toolbox


The use of asparaginase to reduce acrylamide in certain food processing applications is included in both the U.S. Food and Drug Administration's  Draft Guidance for Industry: Acrylamide in Foods, as well as FoodDrinkEurope's Acrylamide Toolbox.

Asparaginase Featured in FDA Acrylamide Draft Guidance and FoodDrinkEurope Acrylamide Toolbox2014-01-25T19:42:55-08:00
4 11, 2013

ETA Statement on Chloramphenicol Contamination of Enzyme Preparations


A voluntary recall of enzyme preparations contaminated with the antibiotic chloramphenicol was recently announced by a U.S.-based enzyme company that imported and distributed the affected product.  The chloramphenicol-contaminated enzyme products were imported from a small enzyme producer located in India.  It has been reported that contaminated enzyme products from this Indian producer have also been imported into Europe, Japan and Canada. The safety and quality of our products is of paramount importance to the enzyme industry.  The industry is working with the U.S. Food and Drug Administration (“FDA”), the Canadian Food Inspection Agency (“CFIA”), the European Food Safety Authority (“EFSA”), and the Food Safety Commission of Japan (“FSCJ”).  The contaminated enzymes were [...]

ETA Statement on Chloramphenicol Contamination of Enzyme Preparations2013-11-04T19:47:28-08:00
7 05, 2012

Bespoke Enzymes Push The Envelope


Designed metalloenzymes made by modifying a native protein scaffold have shown unusually high levels of efficiency and longevity and have revealed new details about the way oxidases, the natural enzymes they mimic, may work. The study is an important step in efforts to design customized enzymes for a variety of potential biological and alternative-energy applications. Full article here.

Bespoke Enzymes Push The Envelope2012-05-07T14:15:50-07:00
13 04, 2012



FDA has extended the agency's memorandum of understanding (MOU) with the Association of American Feed Control Officials (AAFCO) through September 1, 2013.   FDA will likely stop accepting requests to review new feed ingredient definitions in February, 2012.  The full letter from FDA may be downloaded here: FDA response letter AAFCO MOU 4-5-12

FDA Extends AAFCO MOU2012-04-13T14:25:03-07:00
9 04, 2012

Health Canada Publishes New Enzyme Monographs and Consultation Period


The Natural Health Products Directorate (NHPD) will be seeking your feedback on proposed revisions to the enzyme abbreviated labelling standards (AbLS). In September 2011, NHPD published 12 AbLS for enzyme ingredients outlining the minimum documentation requirements and specifications for products containing these enzymes. Since posting the new AbLS, NHPD has been consulting with stakeholders regarding the requirements for products containing enzymes.  As a result of these consultations, NHPD has revised the 12 AbLS for enzymes and developed a new Multi-Ingredient Enzyme AbLS. These will be published for a 30-day consultation period. Consultation starts from the time the documents are officially posted on the Health Canada website. Proposed Revised and New Enzyme Abbreviated [...]

Health Canada Publishes New Enzyme Monographs and Consultation Period2012-04-09T18:14:07-07:00
Go to Top